H. Olivecrona

722 total citations
45 papers, 529 citations indexed

About

H. Olivecrona is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Olivecrona has authored 45 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Olivecrona's work include Growth Hormone and Insulin-like Growth Factors (6 papers), Inflammasome and immune disorders (6 papers) and Meningioma and schwannoma management (5 papers). H. Olivecrona is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (6 papers), Inflammasome and immune disorders (6 papers) and Meningioma and schwannoma management (5 papers). H. Olivecrona collaborates with scholars based in Sweden, United States and Finland. H. Olivecrona's co-authors include B Angelin, S Ericsson, H Rorsman, A. M�ller, A. Hatam, Lars Berglund, Mats Rudling, Gösta Eggertsen, G Nylander and Klaes Golman and has published in prestigious journals such as Science, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

H. Olivecrona

42 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Olivecrona Sweden 15 142 123 90 84 78 45 529
A. Vicari Italy 10 119 0.8× 115 0.9× 95 1.1× 52 0.6× 42 0.5× 24 669
Jocelyne E. Kaufmann Switzerland 8 44 0.3× 139 1.1× 171 1.9× 63 0.8× 54 0.7× 8 616
Inmaculada Noguera Spain 14 59 0.4× 84 0.7× 248 2.8× 68 0.8× 74 0.9× 32 741
Bernadette Curry Canada 15 95 0.7× 141 1.1× 130 1.4× 17 0.2× 93 1.2× 26 838
Nicholas R Hoyle United Kingdom 13 69 0.5× 113 0.9× 289 3.2× 15 0.2× 61 0.8× 20 827
R. Montz Germany 12 28 0.2× 137 1.1× 77 0.9× 170 2.0× 67 0.9× 79 794
Maie Kaarsoo Herrick United States 15 70 0.5× 160 1.3× 246 2.7× 19 0.2× 95 1.2× 25 730
Zhongjing Wang China 14 79 0.6× 75 0.6× 208 2.3× 55 0.7× 40 0.5× 35 469
Ichiro Abe Japan 14 362 2.5× 215 1.7× 112 1.2× 54 0.6× 327 4.2× 47 754
K Frost-Larsen Denmark 15 273 1.9× 147 1.2× 104 1.2× 37 0.4× 71 0.9× 30 999

Countries citing papers authored by H. Olivecrona

Since Specialization
Citations

This map shows the geographic impact of H. Olivecrona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Olivecrona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Olivecrona more than expected).

Fields of papers citing papers by H. Olivecrona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Olivecrona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Olivecrona. The network helps show where H. Olivecrona may publish in the future.

Co-authorship network of co-authors of H. Olivecrona

This figure shows the co-authorship network connecting the top 25 collaborators of H. Olivecrona. A scholar is included among the top collaborators of H. Olivecrona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Olivecrona. H. Olivecrona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldbach‐Mansky, Raphaela, et al.. (2015). THU0514 Effect of Long-Term Treatment with Anakinra (Kineret®) on Bone Mineral Density in Patients with Severe Cryopyrin-Associated Periodic Syndromes. Annals of the Rheumatic Diseases. 74. 386–386. 1 indexed citations
2.
Olivecrona, H., Karin Söderberg, B. Hallén, et al.. (2013). OP0061 Kineret® (Anakinra) Controls Disease Symptoms in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS): Up to 5-Year Follow-Up Data. Annals of the Rheumatic Diseases. 72. A70–A71. 2 indexed citations
3.
Leinonen, M., Karin Söderberg, H. Olivecrona, et al.. (2013). SAT0440 The IL-1RA Antagonist Kineret® (Anakinra) Stabilizes Hearing Loss in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS). Annals of the Rheumatic Diseases. 72. A730–A731. 1 indexed citations
4.
Weidenhielm, Lars, et al.. (2008). Model studies on segmental movement in lumbar spine using a semi-automated program for volume fusion. Computer Aided Surgery. 13(1). 14–22. 7 indexed citations
5.
Lindforss, Ulrik, Nikos Papadogiannakis, Henrik Zetterquist, Greger Lindberg, & H. Olivecrona. (2003). Distribution of genetic variants in preneoplastic areas of colorectal tumours. European Journal of Surgical Oncology. 29(6). 491–496. 6 indexed citations
6.
Olivecrona, H., et al.. (2003). Model Studies on Acetabular Component Migration in Total Hip Arthroplasty using Ct and a Semiautomated Program for Volume Merging. Acta Radiologica. 44(4). 419–429. 25 indexed citations
7.
Ellis, Ewa, et al.. (2002). GH is a regulator of IGF2 promoter-specific transcription in human liver. Journal of Endocrinology. 172(3). 457–465. 26 indexed citations
8.
Rudling, Mats, H. Olivecrona, Gösta Eggertsen, & B Angelin. (1996). Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.. Journal of Clinical Investigation. 97(2). 292–299. 57 indexed citations
9.
Olivecrona, H., et al.. (1994). CT diagnosis of retinoblastoma with histopathologic correlations. European Radiology. 4(4). 307–313. 6 indexed citations
10.
Olivecrona, H., S Ericsson, Lars Berglund, & B Angelin. (1993). Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment.. BMJ. 306(6894). 1726.2–1727. 59 indexed citations
11.
Angelin, Bo, et al.. (1992). Effects of growth hormone on low-density lipoprotein metabolism.. PubMed. 383. 67–8; discussion 69. 8 indexed citations
12.
Jennische, Eva & H. Olivecrona. (1987). Transient expression of insulin‐like growth factor I immunoreactivity in skeletal muscle cells during postnatal development in the rat. Acta Physiologica Scandinavica. 131(4). 619–622. 22 indexed citations
13.
Hindmarsh, T., G. Bergstrand, K. Ericson, & H. Olivecrona. (1983). Comparative double-blind investigation of meglumine metrizoate, metrizamide, and iohexol in carotid angiography.. American Journal of Neuroradiology. 4(3). 347–349. 6 indexed citations
14.
Nylander, G & H. Olivecrona. (1976). The phlebographic pattern of acute leg thrombosis within a defined urban population.. PubMed. 142(7). 505–11. 21 indexed citations
15.
Landberg, T., et al.. (1972). Treatment of Inoperable Pulmonary Tumours with High-Energy Electrons. Acta Radiologica Therapy Physics Biology. 11(2). 172–191. 1 indexed citations
16.
Agrup, G, B. Falck, H. Olivecrona, & H Rorsman. (1971). Formaldehyde-induced fluorescence of epidermal melanocytes of caucasian and negro skin. Acta Dermato Venereologica. 51(5). 350–352. 7 indexed citations
17.
Ehinger, B., H. Olivecrona, & H Rorsman. (1967). MALIGNANT MELANOMAS OF THE EYE AS STUDIED WITH A SPECIFIC FLUORESCENCE METHOD. Acta Pathologica Microbiologica Scandinavica. 69(2). 179–184. 4 indexed citations
18.
Olivecrona, H. & H Rorsman. (1966). The effect of roentgen irradiation on the specific fluorescence of epidermal melanocytes.. PubMed. 46(5). 403–5. 10 indexed citations
19.
Olivecrona, H. & H Rorsman. (1966). Specific fluorescence in guinea-pig melanocytes.. PubMed. 46(6). 497–9. 6 indexed citations
20.
Hillarp, N.‐Å., et al.. (1954). Evidence for the participation of the preoptic area in male mating behaviour. Cellular and Molecular Life Sciences. 10(5). 224–225. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Vicari Breakdown of academic impact, for papers by Jocelyne E. Kaufmann Breakdown of academic impact, for papers by Inmaculada Noguera Breakdown of academic impact, for papers by Bernadette Curry Breakdown of academic impact, for papers by Nicholas R Hoyle Breakdown of academic impact, for papers by R. Montz Breakdown of academic impact, for papers by Maie Kaarsoo Herrick Breakdown of academic impact, for papers by Zhongjing Wang Breakdown of academic impact, for papers by Ichiro Abe Breakdown of academic impact, for papers by K Frost-Larsen
Rankless by CCL
2026